Landmark BioVentures AG, founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company.

LBV takes a unique model focused on lean operations, smart capital allocation, and diversified nexus of 7 companies developing 10 first-in-class therapeutics.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2021
  • Number of employees in Switzerland
    1-9

You may also be interested in